UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes

Clinical cancer research, 2009-05, Vol.15 (10), p.3251-3255

2009

Volltextzugriff (PDF)

Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (6), p.2024-2032

2008

Volltextzugriff (PDF)

Phase I Trial of Sorafenib and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort in Advanced Pancreatic Cancer

Clinical cancer research, 2006-01, Vol.12 (1), p.144-151

2006

Volltextzugriff (PDF)

Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials

Cancer chemotherapy and pharmacology, 2008-04, Vol.61 (4), p.535-548

2008

Volltextzugriff (PDF)

Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function

Clinical cancer research, 2007-08, Vol.13 (16), p.4832-4839

2007

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2003-01, Vol.21 (1), p.148-157

2003

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer

Clinical cancer research, 2007-05, Vol.13 (9), p.2675-2683

2007

Volltextzugriff (PDF)

Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study

Clinical cancer research, 2007-06, Vol.13 (12), p.3660-3666

2007

Volltextzugriff (PDF)

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2664-2672

2003

Volltextzugriff (PDF)

Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas

Clinical cancer research, 2005-11, Vol.11 (21), p.7866-7871

2005

Volltextzugriff (PDF)

Phase 1 Study of AMG 386, a Selective Angiopoietin 1/2-Neutralizing Peptibody, in Combination with Chemotherapy in Adults with Advanced Solid Tumors

Clinical cancer research, 2010-06, Vol.16 (11), p.3044-3056

2010

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Bortezomib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction: Phase I NCI Organ Dysfunction Working Group Study NCI-6432

Clinical cancer research, 2012-05, Vol.18 (10), p.2954-2963

2012

Volltextzugriff (PDF)

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Clinical cancer research, 2006-01, Vol.12 (2), p.536-542

2006

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Squalamine, an Aminosterol Angiogenesis Inhibitor

Clinical cancer research, 2003-07, Vol.9 (7), p.2465-2471

2003

Volltextzugriff (PDF)

Phase 0 clinical trials in oncology: a paradigm shift for early drug development?

Cancer chemotherapy and pharmacology, 2009-03, Vol.63 (4), p.703-709

Takimoto, Chris H

2009

Volltextzugriff (PDF)

A Phase I, Pharmacokinetic, and Biological Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Gemcitabine in Patients with Advanced Malignancies

Clinical cancer research, 2003-10, Vol.9 (13), p.4761-4771

2003

Volltextzugriff (PDF)

Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

Cancer chemotherapy and pharmacology, 2011-12, Vol.68 (6), p.1439-1447

2011

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-12, Vol.11 (24), p.8728-8736

2005

Volltextzugriff (PDF)

Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788

Clinical cancer research, 2012-11, Vol.18 (22), p.6364-6372

2012

Volltextzugriff (PDF)

Chronomodulated chemotherapy for colorectal cancer: Failing the test of time?

European journal of cancer (1990), 2006-03, Vol.42 (5), p.574-581

Takimoto, Chris H.

2006

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of ILX-295501, an Oral Diarylsulfonylurea, on a Weekly for 3 Weeks Every 4-Week Schedule in Patients with Advanced Solid Malignancies

Clinical cancer research, 2003-11, Vol.9 (15), p.5540-5549

2003

Volltextzugriff (PDF)

Anticancer drug development at the US National Cancer Institute

Cancer chemotherapy and pharmacology, 2003-07, Vol.52, p.S29-S33

TAKIMOTO, Chris H

2003

Volltextzugriff (PDF)

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies

Cancer chemotherapy and pharmacology, 2009-07, Vol.64 (2), p.287-295

2009

Volltextzugriff (PDF)

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

Cancer chemotherapy and pharmacology, 2012-03, Vol.69 (3), p.825-834

2012

Volltextzugriff (PDF)

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2012-02, Vol.69 (2), p.563-571

2012

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes

Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice

Phase I Trial of Sorafenib and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort in Advanced Pancreatic Cancer

Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials

Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer

Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas

Phase 1 Study of AMG 386, a Selective Angiopoietin 1/2-Neutralizing Peptibody, in Combination with Chemotherapy in Adults with Advanced Solid Tumors

Pharmacokinetics and Safety of Bortezomib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction: Phase I NCI Organ Dysfunction Working Group Study NCI-6432

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

A Phase I and Pharmacokinetic Study of Squalamine, an Aminosterol Angiogenesis Inhibitor

Phase 0 clinical trials in oncology: a paradigm shift for early drug development?

A Phase I, Pharmacokinetic, and Biological Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Gemcitabine in Patients with Advanced Malignancies

Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788

Chronomodulated chemotherapy for colorectal cancer: Failing the test of time?

A Phase I and Pharmacokinetic Study of ILX-295501, an Oral Diarylsulfonylurea, on a Weekly for 3 Weeks Every 4-Week Schedule in Patients with Advanced Solid Malignancies

Anticancer drug development at the US National Cancer Institute

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern